Since guidelines for treating ischemic mitral regurgitation (IMR) in patients undergoing coronary artery bypass grafting (CABG) have changed over time, this study aimed to assess the real-world impact of that change. Researchers found that, although the rate of valve replacement for severe IMR did not change, patients with moderate IMR were less likely to undergo replacement.
You are here:
Contemporary Management of Ischemic Mitral Regurgitation at Coronary Artery Bypass Grafting
Submitted by: Cameron Lind
Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2022.08.046
Keywords:
Author(s): Michael J. Pienta, MD, MS, Patty Theurer, MSN, Chang He, MS, Melissa Clark, MSN,Jonathan Haft, MD, Steven F. Bolling, MD, Charles Willekes, MD, Hassan Nemeh, MD,Richard L. Prager, MD, Matthew A. Romano, MD, and Gorav Ailawadi, MD, MBA, on behalf ofthe Michigan Society of Thoracic and Cardiovascular Surgery Quality Collaborative
